{"id":"https://openalex.org/W4288040102","doi":"https://doi.org/10.1158/2326-6066.cir-21-0253","title":"Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling","display_name":"Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling","publication_year":2022,"publication_date":"2022-07-26","ids":{"openalex":"https://openalex.org/W4288040102","doi":"https://doi.org/10.1158/2326-6066.cir-21-0253","pmid":"https://pubmed.ncbi.nlm.nih.gov/35881865"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-21-0253","doi":"https://doi.org/10.1158/2326-6066.cir-21-0253","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-21-0253","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085713573","display_name":"Regina Lin","orcid":"https://orcid.org/0000-0002-4811-538X","observed_orcids":["https://orcid.org/0000-0002-4811-538X"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Regina J. Lin","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-4811-538X","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081317739","display_name":"Andrew R. Nager","orcid":"https://orcid.org/0000-0002-2909-9767","observed_orcids":["https://orcid.org/0000-0002-2909-9767"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Andrew R. Nager","raw_affiliation_strings":["2Pfizer, Inc., San Diego, California"],"raw_orcid":"https://orcid.org/0000-0002-2909-9767","affiliations":[{"raw_affiliation_string":"2Pfizer, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012599479","display_name":"Spencer Park","orcid":"https://orcid.org/0000-0003-4848-3112","observed_orcids":["https://orcid.org/0000-0003-4848-3112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Spencer Park","raw_affiliation_strings":["2Pfizer, Inc., San Diego, California"],"raw_orcid":"https://orcid.org/0000-0003-4848-3112","affiliations":[{"raw_affiliation_string":"2Pfizer, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072045494","display_name":"Janette E. Sutton","orcid":"https://orcid.org/0000-0002-4580-9319","observed_orcids":["https://orcid.org/0000-0002-4580-9319"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janette Sutton","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-4580-9319","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063004323","display_name":"Cecilia Lay","orcid":"https://orcid.org/0000-0001-5896-0416","observed_orcids":["https://orcid.org/0000-0001-5896-0416"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecilia Lay","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0001-5896-0416","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046589842","display_name":"Zea Melton","orcid":"https://orcid.org/0000-0002-9912-9968","observed_orcids":["https://orcid.org/0000-0002-9912-9968"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zea Melton","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-9912-9968","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017123672","display_name":"Yi Zhang","orcid":"https://orcid.org/0000-0003-1878-343X","observed_orcids":["https://orcid.org/0000-0003-1878-343X"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Zhang","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0003-1878-343X","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017436409","display_name":"Bijan A. Boldajipour","orcid":"https://orcid.org/0000-0003-2065-555X","observed_orcids":["https://orcid.org/0000-0003-2065-555X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bijan Boldajipour","raw_affiliation_strings":["2Pfizer, Inc., San Diego, California"],"raw_orcid":"https://orcid.org/0000-0003-2065-555X","affiliations":[{"raw_affiliation_string":"2Pfizer, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017840971","display_name":"Thomas J. Van Blarcom","orcid":"https://orcid.org/0000-0003-0111-1661","observed_orcids":["https://orcid.org/0000-0003-0111-1661"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Van Blarcom","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0003-0111-1661","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077319979","display_name":"Siler H. Panowski","orcid":"https://orcid.org/0000-0001-7488-3086","observed_orcids":["https://orcid.org/0000-0001-7488-3086"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siler H. Panowski","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0001-7488-3086","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045876748","display_name":"Barbra Johnson Sasu","orcid":"https://orcid.org/0000-0002-4394-7339","observed_orcids":["https://orcid.org/0000-0002-4394-7339"]},"institutions":[{"id":"https://openalex.org/I4210103816","display_name":"Allogene Therapeutics (United States)","ror":"https://ror.org/01at8a333","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barbra J. Sasu","raw_affiliation_strings":["1Allogene Therapeutics, Inc., San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-4394-7339","affiliations":[{"raw_affiliation_string":"1Allogene Therapeutics, Inc., San Francisco, California","institution_ids":["https://openalex.org/I4210103816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042641999","display_name":"Javier F. Chaparro\u2010Riggers","orcid":"https://orcid.org/0000-0002-5403-966X","observed_orcids":["https://orcid.org/0000-0002-5403-966X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Javier Chaparro-Riggers","raw_affiliation_strings":["2Pfizer, Inc., San Diego, California"],"raw_orcid":"https://orcid.org/0000-0002-5403-966X","affiliations":[{"raw_affiliation_string":"2Pfizer, Inc., San Diego, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5042641999","https://openalex.org/A5045876748","https://openalex.org/A5081317739"],"corresponding_institution_ids":["https://openalex.org/I4210103816"],"apc_list":null,"apc_paid":null,"fwci":0.732,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.69840118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"9","first_page":"1069","last_page":"1083"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-engineering","display_name":"CAR-T cell engineering","score":0.6269999742507935},{"id":"https://openalex.org/keywords/cytokine-toxicity","display_name":"cytokine toxicity","score":0.628000020980835},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.949999988079071}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.7237324118614197},{"id":"https://openalex.org/C14077384","wikidata":"https://www.wikidata.org/wiki/Q18033186","display_name":"Suppressor of cytokine signaling 1","level":4,"score":0.6666595935821533},{"id":"https://openalex.org/C162354598","wikidata":"https://www.wikidata.org/wiki/Q7644655","display_name":"Suppressor of cytokine signalling","level":5,"score":0.5808940529823303},{"id":"https://openalex.org/C126042315","wikidata":"https://www.wikidata.org/wiki/Q18033763","display_name":"SOCS3","level":4,"score":0.5706138610839844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5382207632064819},{"id":"https://openalex.org/C2775855021","wikidata":"https://www.wikidata.org/wiki/Q968436","display_name":"Cytokine receptor","level":3,"score":0.5374830961227417},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5293175578117371},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.41778868436813354},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.37590309977531433},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3053323030471802},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09547728300094604},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0767596960067749},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.07532641291618347},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.cir-21-0253","doi":"https://doi.org/10.1158/2326-6066.cir-21-0253","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-21-0253","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:35881865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35881865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W1505221840","https://openalex.org/W1571148007","https://openalex.org/W1803183847","https://openalex.org/W1980284146","https://openalex.org/W1982795546","https://openalex.org/W1999574084","https://openalex.org/W2011395179","https://openalex.org/W2025122282","https://openalex.org/W2030819935","https://openalex.org/W2031537098","https://openalex.org/W2039211544","https://openalex.org/W2061275688","https://openalex.org/W2085424263","https://openalex.org/W2086422527","https://openalex.org/W2105879190","https://openalex.org/W2114104545","https://openalex.org/W2116089582","https://openalex.org/W2118796952","https://openalex.org/W2122465970","https://openalex.org/W2132921981","https://openalex.org/W2135450099","https://openalex.org/W2138739892","https://openalex.org/W2143381422","https://openalex.org/W2146678347","https://openalex.org/W2154740756","https://openalex.org/W2160443244","https://openalex.org/W2169456326","https://openalex.org/W2178727026","https://openalex.org/W2342423058","https://openalex.org/W2569710884","https://openalex.org/W2610643018","https://openalex.org/W2613407096","https://openalex.org/W2617490000","https://openalex.org/W2651055861","https://openalex.org/W2738678436","https://openalex.org/W2743510679","https://openalex.org/W2747383311","https://openalex.org/W2750694869","https://openalex.org/W2787578932","https://openalex.org/W2787621143","https://openalex.org/W2789780246","https://openalex.org/W2801641802","https://openalex.org/W2804588678","https://openalex.org/W2807819616","https://openalex.org/W2891537049","https://openalex.org/W2911882091","https://openalex.org/W2917127842","https://openalex.org/W2936355201","https://openalex.org/W2937806960","https://openalex.org/W2943335541","https://openalex.org/W2953962991","https://openalex.org/W2970727076","https://openalex.org/W2983000998","https://openalex.org/W3012325124","https://openalex.org/W3037602706"],"related_works":["https://openalex.org/W4385565559","https://openalex.org/W3182175525","https://openalex.org/W4311450808","https://openalex.org/W2903363651","https://openalex.org/W4393090592","https://openalex.org/W4385969621","https://openalex.org/W3081637392","https://openalex.org/W3004836354","https://openalex.org/W4389175257","https://openalex.org/W4390030675"],"abstract_inverted_index":{"Although":[0],"cytokine":[1,39,60,71,109],"support":[2],"can":[3,18],"enhance":[4],"CAR":[5,12],"T-cell":[6],"function,":[7],"coadministering":[8],"cytokines":[9,17],"or":[10],"engineering":[11],"T":[13,30,116],"cells":[14,31,117],"to":[15,51],"secrete":[16],"result":[19],"in":[20,123],"toxicities.":[21],"To":[22],"mitigate":[23],"these":[24],"safety":[25],"risks,":[26],"we":[27],"engineered":[28],"iTurboCAR":[29,115],"that":[32,48,73,83,104],"coexpress":[33],"a":[34,52,79],"novel":[35],"inducible":[36],"Turbo":[37],"(iTurbo)":[38],"signaling":[40,61,66,103,135],"domain.":[41],"iTurbo":[42,76,90,100,112,127],"domains":[43,77,101,113],"consist":[44],"of":[45,54],"modular":[46],"components":[47],"are":[49,74],"customizable":[50],"variety":[53],"activating":[55],"inputs,":[56],"as":[57,59],"well":[58],"outputs":[62],"multiplexable":[63],"for":[64,133],"combinatorial":[65],"outcomes.":[67],"Unlike":[68],"most":[69],"canonical":[70],"receptors":[72],"heterodimeric,":[75],"leverage":[78],"compact,":[80],"homodimeric":[81,99],"design":[82],"minimizes":[84],"viral":[85,146],"vector":[86],"cargo.":[87],"Using":[88],"an":[89],"domain":[91],"activated":[92],"by":[93],"the":[94,106,131],"clinically":[95],"validated":[96],"dimerizer,":[97],"AP1903,":[98],"instigated":[102],"mimicked":[105],"endogenous":[107],"heterodimeric":[108],"receptor.":[110],"Different":[111],"programmed":[114],"toward":[118],"divergent":[119],"phenotypes":[120],"and":[121,142],"resulted":[122],"improved":[124],"antitumor":[125],"efficacy.":[126],"domains,":[128],"therefore,":[129],"offer":[130],"flexibility":[132],"user-programmable":[134],"outputs,":[136],"permitting":[137],"control":[138],"over":[139],"cellular":[140],"phenotype":[141],"function":[143],"while":[144],"minimizing":[145],"cargo":[147],"footprint.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-07-27T00:00:00"}